Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth arrest-specific transcript 5 (GAS5) is a long non-coding RNA encoded at chromosome 1q25.1, and comprises 12 exons. It does not code for a protein, but rather regulates gene expression by acting as a molecular sponge for miRNAs, serving as a scaffold/guide for transcription factors, and influencing multiple cell signaling pathways including mTOR, p53, AKT, and glucocorticoid receptor signaling. GAS5 is a known tumor suppressor, with decreased expression observed in many cancers and neurodegenerative diseases. In neurons and metabolic tissues, GAS5 modulates insulin signaling and neuroinflammation, and its levels are reduced in conditions such as type 2 diabetes and Alzheimer's disease. GAS5 is being explored as both a biomarker and a therapeutic target, with small-molecule modulators like NPC86 showing preclinical promise for disease intervention. Regulation of cell proliferation, apoptosis, stem cell self-renewal, and neuronal survival are among its key biological processes.
Small molecules such as NPC86 bind GAS5, increase its expression, enhance insulin receptor levels, and modulate neuroinflammation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Growth arrest-specific transcript 5 (GAS5).